Possible involvement of p44/p42 MAP kinase in retinoic acid-stimulated vascular endothelial growth factor release in aortic smooth muscle cells

Atherosclerosis

Volumn 175, Issue 2, 2004, Pages 245-251

  Tanabe, Kumiko ^a   Hirade, Kouseki ^b   Ishisaki, Akira ^a   Shu, En ^a   Suga, Hidetaka ^a   Kitajima, Yasuo ^a   Katagiri, Yoshihiro ^b   Dohi, Shuji ^a   Kozawa, Osamu ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

MAP kinase; Retinoic acid; Vascular smooth muscle cells; VEGF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DACTINOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; RETINOIC ACID; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANIMAL CELL; AORTA; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; CELL CULTURE TECHNIQUES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; RATS; TRETINOIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3242709525     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.05.002     Document Type: Article

References (35)

1. Gardner DG, Chen S Retinoids and cell growth in the cardiovascular system. Life Sci. 65:1999;1607-1613
2. Miano JM, Berk BC Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. Circ Res. 87:2000;355-362
3. Neuville P, Bochaton-Piallat M-L, Gabbiani G Retinoids and arterial smooth muscle cells. Arterioscler Thromb Vasc Biol. 20:2000;1882-1888
4. Hungerford JE, Little CD Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J Vasc Res. 36:1999;2-27
5. Ross R Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126
6. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22
7. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. J Biol Chem. 266:1991;11947-11954
8. Brogi E, Wu T, Namiki A, Isner JM Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation. 90:1994;649-652
9. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation. 92:1995;11-14
10. Pedram A, Razandi M, Hu RM, Levin ER Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem. 272:1997;17097-17103
11. Jung YD, Liu W, Reinmuth N, et al. Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the p38 mitogen-activated protein kinase pathway. Angiogenesis. 4:2001;155-162
12. Widmann C, Gibson S, Jarpe MB, Johnson GL Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 79:1999;143-180
13. Chang L, Karin M Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40
14. Marrero MB, Schieffer B, Li B, et al. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem. 272:1997;24684-24690
15. Jiang B, Brecher P, Cohen RA Persistent activation of nuclear factor-κB by interleukin-1β and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler Thromb Vasc Biol. 21:2001;1915-1920
16. Yamakawa T, Eguchi S, Matsumoto T, et al. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-κB and p38 mitogen-activated protein kinase on tumor necrosis factor-α production. Endocrinology. 140:1999;3562-3573
17. Yamamoto T, Kozawa O, Tanabe K, et al. Involvement of p38 MAP kinase in TGF-β-stimulated VEGF synthesis in aortic smooth muscle cells. J Cell Biochem. 82:2001;591-598
18. 3 stimulates vascular endothelial growth factor release in aortic smooth muscle cells: role of p38 mitogen-activated protein kinase. Arch Biochem Biophys. 398:2002;1-6
19. Kimes BW, Brandt BL Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res. 98:1976;349-366
20. Seko Y, Seko Y, Takahashi N, Shibuya M, Yazaki Y Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun. 254:1999;462-465
21. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
22. Actinomycins. IARC Monogr Eval Carcinog Risk Chem Man 10 1976;10;29-41
23. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 92:1995;7686-7689
24. Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 273:1998;18623-18632
25. Diaz BV, Lenoir M-C, Ladoux A, et al. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J Biol Chem. 275:2000;642-650
26. Kini AR, Peterson LC, Tallman MS, Lingen MW Angiogeneis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all trans retinoic acid. Blood. 97:2001;3919-3924
27. Maeno T, Tanaka T, Sando Y, et al. Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Spl and Sp3 sites in human bronchioalveolar carcinoma cells. Am J Respir Cell Mol Biol. 26:2002;246-253
28. Miano JM, Berk BC Retinoids: new insight into smooth muscle cell growth inhibition. Arterioscler Thromb Vasc Biol. 21:2001;724-726
29. Ferrara N, Davis-Smyth T The biology of vascular endothelial growth factor. Endocrine Reviews. 18:1997;4-25
30. Raingeaud J, Gupta S, Rogers JS, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 270:1995;7420-7426
31. Yen A, Roberson MS, Varvayanis S Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell Dev Biol Anim. 35:1999;527-532
32. Alsayed Y, Uddin S, Mahmud N, et al. Activation of rac1 and the p38 mitogen-activated protein kinase pathway in response to all trans-retinoic acid. J Biol Chem. 276:2001;4012-4019
33. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ Res. 81:1997;575-584
34. Yang C-M, Chien C-S, Hsiao L-D, et al. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway. Br J Phrmacol. 132:2001;1531-1541
35. Pal S, Iruela-Arispe ML, Harvey VS, et al. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade. Microvasc Res. 60:2000;112-120